Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$11.47
-1.8%
$11.73
$5.98
$13.65
$220.72M1.4246,583 shs18,876 shs
SEPA
SEP Acquisition
$10.32
+1.3%
$10.19
$7.86
$17.00
$59.96M0.1511,589 shs7,000 shs
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$24.16
0.0%
$28.16
$23.53
$39.08
$214.82M1.2649,393 shs51,420 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.76
-0.2%
$11.07
$8.15
$19.44
$523.25M2.191.15 million shs514,225 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
-1.80%-2.22%-10.39%+27.16%+58.43%
SEPA
SEP Acquisition
0.00%0.00%0.00%0.00%0.00%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-0.04%-5.37%-19.31%-26.54%-24.24%
ZimVie Inc. stock logo
ZIMV
ZimVie
-0.16%+0.21%+87.41%+100.43%-11.26%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
3.241 of 5 stars
2.55.00.00.03.90.81.9
SEPA
SEP Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1.599 of 5 stars
3.51.00.00.00.61.70.6
ZimVie Inc. stock logo
ZIMV
ZimVie
0.9234 of 5 stars
1.05.00.00.01.91.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
3.00
Buy$14.2524.24% Upside
SEPA
SEP Acquisition
0.00
N/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
3.00
Buy$49.50104.88% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.00
Hold$17.75-5.38% Downside

Current Analyst Ratings Breakdown

Latest SEPA, ZIMV, SMTI, and BWAY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/31/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$19.00
7/22/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$9.00 ➝ $19.00
6/9/2025
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00
5/15/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$51.00 ➝ $53.00
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$41.02M5.28$0.24 per share46.84$3.31 per share3.47
SEPA
SEP Acquisition
N/AN/AN/AN/A($0.63) per shareN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$86.67M2.48N/AN/A$4.45 per share5.43
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M1.16$1.85 per share10.12$14.82 per share1.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$2.92M$0.2057.3571.69N/A9.01%7.35%4.72%8/5/2025 (Estimated)
SEPA
SEP Acquisition
-$2.36MN/A0.00N/AN/AN/A-38.32%N/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$9.66M-$1.34N/AN/AN/A-12.48%-29.22%-13.20%8/13/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.70N/AN/A-4.39%6.37%3.34%8/7/2025 (Estimated)

Latest SEPA, ZIMV, SMTI, and BWAY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$0.07N/AN/AN/A$12.34 millionN/A
8/13/2025Q2 2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.33N/AN/AN/A$25.15 millionN/A
8/7/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2285N/AN/AN/A$112.82 millionN/A
7/30/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
N/A$0.26N/A-$0.14$112.60 million$116.66 million
5/14/2025Q1 2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.31-$0.41-$0.10-$0.41$23.48 million$23.43 million
5/13/2025Q1 2025
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$0.02$0.04+$0.02$0.04$11.45 million$11.54 million
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
N/AN/AN/AN/AN/A
SEPA
SEP Acquisition
N/AN/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
N/A
5.03
4.75
SEPA
SEP Acquisition
N/A
0.57
0.57
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1.18
2.77
2.54
ZimVie Inc. stock logo
ZIMV
ZimVie
0.56
2.37
1.48

Institutional Ownership

CompanyInstitutional Ownership
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
30.11%
SEPA
SEP Acquisition
3.66%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
8.10%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
19.00%
SEPA
SEP Acquisition
20.00%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
42.60%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
12018.90 million15.31 millionNot Optionable
SEPA
SEP Acquisition
25.81 million4.65 millionNot Optionable
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
608.89 million5.10 millionNot Optionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77027.85 million27.01 millionOptionable

Recent News About These Companies

ZimVie (NASDAQ:ZIMV) Downgraded by B. Riley to "Neutral"
ZimVie (NASDAQ:ZIMV) Releases Quarterly Earnings Results
ZimVie (ZIMV) Projected to Post Earnings on Thursday
ZimVie Reports Second Quarter 2025 Financial Results
Insights into ZimVie's Upcoming Earnings
ZimVie to sell to investment firm for about $730M
BC-Most Active Stocks
...
ZimVie Inc to be Acquired by ARCHIMED

New MarketBeat Followers Over Time

Media Sentiment Over Time

Brainsway stock logo

Brainsway NASDAQ:BWAY

$11.47 -0.21 (-1.80%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$11.95 +0.48 (+4.22%)
As of 08/1/2025 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

SEP Acquisition NASDAQ:SEPA

SEP Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was formerly known as Mercury Ecommerce Acquisition Corp. and changed its name to SEP Acquisition Corp. in December 2022. The company was incorporated in 2021 and is based in Houston, Texas. SEP Acquisition Corp. is a subsidiary of Mercury Sponsor Group I LLC.

Sanara MedTech stock logo

Sanara MedTech NASDAQ:SMTI

$24.16 -0.01 (-0.04%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$25.36 +1.20 (+4.98%)
As of 08/1/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$18.76 -0.03 (-0.16%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$18.76 0.00 (0.00%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.